Table 7. Recommendations – benefits and risks of T Therapy.
| Benefits and risks of testosterone therapy in men with testosterone deficiency | LoE | Grade |
|---|---|---|
| Beyond 6 months there is evidence of benefit for T Therapy in body composition, bone mineralisation and features of metabolic syndrome | 3 | A |
| Testosterone Therapy improves sexual desire, erectile function and sexual satisfaction | 1 | A |
| A reduction in BMI, waist size, improved glycaemic control and lipid profile are observed in hypogonadal men receiving T Therapy | 2 | A |
| Trials of T Therapy should be at least 6 months and maximal benefit is often seen beyond 12 months | 2 | A |
| Fully inform the patient about expected benefits and side-effects of therapy and facilitate a joint decision by an informed patient and physician | 3 | A |
| Fully discuss the adverse impact of T Therapy and its reversibility for future fertility and offer alternative treatment as necessary | 1b | B |
| In patients with adult-onset TD, when T Therapy is prescribed, offer additional weight loss and lifestyle advice as standard management | 2 | A |
| In severely symptomatic patients with TT levels below 8 nmol/L, lifestyle and dietary advice alone is unlikely to produce meaningful clinical improvement within a relevant clinical period | 2 | B |
T Therapy: testosterone therapy, BMI: body mass index, TD: testosterone deficiency, TT: total testosterone.